Nasal spray to treat social anxiety disorder lacks abuse potential: FDA Dr. Kamal Kant Kohli16 May 2022 8:00 PM ISTThe FDA has announced that PH94B a new intranasal drug to treat acute social anxiety in adults being produced by VistaGen Therapeutics lacks the...
FDA approves Tirzepatide for controlling blood sugar in type 2 diabetes patients Dr. Kamal Kant Kohli14 May 2022 12:15 PM ISTThe US Food and Drug Administratio has granted approval to tirzepatide (Mounjaro) injection for treatment of patients with type 2 diabetes. ...
TMS approved as adjunct treatment for OCD by FDA Dr. Kamal Kant Kohli13 May 2022 10:15 AM ISTThe US food and drug administration has approved transcranial magnetic stimulation system, called NeuroStar, as an adjunct treatment for patients with...
Cytisinicline helps achieve significant improvement in smoking cessation: ORCA-2 topline results Dr. Kamal Kant Kohli9 May 2022 1:45 PM ISTThe topline results from ongoing phase 3 ORCA-2 trial have revealed that Cytisinicline resulted in clinically robust and significant improvements in...
Non invasive Hypothermic therapy system promising for treatment of concussions MD Bureau6 May 2022 9:45 AM ISTPro2cool device a noninvasive hypothermic therapy system for treating concussions has been developed by TecTraum Inc.The device is supposed to...
Health Bulletin 4/May/2022 Roshni Dhar4 May 2022 5:24 PM ISTHere are the top health stories for the day: Mandatory yoga for MBBS: NMC releases common yoga protocol to be followed by allReferring to...
Radiofrequency heating plus electromagnetic stimulation reduces belly fat and increases muscle Dr. Kamal Kant Kohli4 May 2022 9:00 AM IST"Our study, the first randomized trial of the combined RF and HIFEM procedure, documents a significant reduction in abdominal fat with an increase in...
Journal Club - FDA approves AVEIR VR leadless pacemaker system to treat patients with slow heart Dr. Nandita Mohan2 May 2022 5:45 PM ISTThe Food and Drug Administration has granted approval to Abbott's Aveir leadless, single-chamber pacemaker system for patients with bradycardia. In...
FDA approves mavacamten for managing symptomatic obstructive hypertrophic cardiomyopathy Dr. Kamal Kant Kohli2 May 2022 10:30 AM ISTThe US Food and Drug Administration has approved mavacamten (Camzyos) for treatment of symptomatic obstructive hypertrophic cardiomyopathy...
Popolymer matrix-based sublingual epinephrine continues to show promise: EPIPHAST study Dr. Kamal Kant Kohli30 April 2022 9:00 AM ISTEpinephrine can reach therapeutic plasma concentrations via sublingual administration confirm researchers during the second part of the ongoing...
Oteseconazole first FDA approved drug for recurrent vulvovaginal candidiasis Medha Baranwal30 April 2022 9:00 AM ISTUSA: The US Food and Drug Administration (FDA) has given approval to oteseconazole (Vivjoa), making it the first medication to be approved for chronic...
FDA approves Epsolay for inflammatory lesions of rosacea Dr. Kamal Kant Kohli26 April 2022 9:00 AM ISTThe US Food and Drug Administration has approved Epsolay cream for the treatment of inflammatory lesions of rosacea, according to Sol-Gel Technologies...
